Loading
CI
Corium International, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Gurnet Holding Co, was filed 28 Nov 2018.
Corium International, Inc.: what insiders have been doing
Corium International, Inc. is a listed company. Its directors and officers file their transactions with SEC (Form 4). Nothing new has been filed by managers of Corium International, Inc. in twelve months, the latest record being from 29 November 2018.
The full history, which starts in 2016, counts 14 purchases against 28 sales.
Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
76
Thresholds
n/a
Buy Volume
€422M
14 ops. · all time
Sell Volume
€49M
28 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2017FY ended September 2017 · cache
Income statement
Revenue28.4M
Net income-42.6M-150.0% margin
Last declaration on 29 November 2018
Declarations76 total
9,353,304 shares@ US$12.50100.0% of flowCommon StockSEC:0001567619-18-007099:0
●
Same trade as the filing by Essex Woodlands Health Ventures Fund VII LP, counted once
117M USD19SEC
9,353,304 shares@ US$12.50100.0% of flowCommon StockSEC:0001567619-18-007097:0
31,578,042 shares@ US$12.5086.2% of flowCommon StockSEC:0001104659-18-070277:0
Canonical exit: 25 Feb 2019 (T+90)
5,051,463 shares@ US$12.5013.8% of flowCommon StockSEC:0001104659-18-070277:1
Canonical exit: 25 Feb 2019 (T+90)
34,203 shares@ US$12.50100.0% of flowCommon StockSEC:0001567619-18-007065:0
12,500 shares@ US$12.5051.0% of flowCommon StockSEC:0001567619-18-007062:0
12,000 shares@ US$12.5049.0% of flowCommon StockSEC:0001567619-18-007062:1
34,801 shares@ US$12.5099.3% of flowCommon StockSEC:0001567619-18-007077:0
14,441 shares@ US$12.5095.4% of flowCommon StockSEC:0001567619-18-007063:0
3,000 shares@ US$12.50100.0% of flowCommon StockSEC:0001567619-18-007070:0
16,689 shares@ US$12.5086.7% of flowCommon StockSEC:0001567619-18-007071:0
16,127 shares@ US$12.5087.8% of flowCommon StockSEC:0001567619-18-007073:0
291,397 shares@ US$12.5063.9% of flowCommon StockSEC:0001567619-18-007075:0
34,878 shares@ US$12.507.6% of flowCommon StockSEC:0001567619-18-007075:1
4,474,995 sharesCommon StockSEC:0000919574-18-007778:0
42,859 shares@ US$2.221.7% of flowCommon StockSEC:0001567619-18-006806:0
282,447 shares@ US$12.516.9% of flowCommon StockSEC:0001012975-18-001109:0
500,000 shares@ US$12.5012.1% of flowCommon StockSEC:0001012975-18-001109:1
500,000 shares@ US$12.5112.1% of flowCommon StockSEC:0001012975-18-001109:2
2,350,000 shares@ US$12.5257.1% of flowCommon StockSEC:0001012975-18-001109:3
2,813 shares0Common StockSEC:0001567619-18-001418:0
1,250 shares0Common StockSEC:0001567619-18-001421:0
7,813 shares0Common StockSEC:0001567619-18-001417:3
2,813 shares0Common StockSEC:0001567619-18-001420:0
6,250 shares0Common StockSEC:0001567619-18-001420:1
25 of 76 declarations
About Corium International, Inc.
Corium International, Inc. is a company focused on developing transdermal pharmaceutical solutions. It aims to enhance drug delivery through the skin.
